Organoids and Artificial Intelligence 🫐

Summary

The episode explores the rapid convergence of organoid technology and artificial intelligence, highlighting how AI-driven image analysis, multidimensional data integration, and high‑throughput screening are transforming organoid research. It introduces the emerging field of Organoid Intelligence, where brain organoids act as biological processors interfaced with AI to create hybrid bio‑computing systems. The discussion also covers precision medicine applications, such as patient‑specific disease modeling, cancer immunotherapy optimization, and drug discovery acceleration, while noting key challenges like scaling organoids, ethical concerns, and data complexity. Several pioneering biotech companies—28Bio, Cortical Labs, Vivodyne, BrainStorm Therapeutics, Curi Bio, PATH Biotech, RUMI Scientific, OrganAId, and ALP AI—are showcased for their AI‑enabled organoid platforms.